LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.

Layne, Richard D / Sehbai, Aasim S / Stark, Linda J

The Annals of pharmacotherapy

2004  Volume 38, Issue 2, Page(s) 232–234

Abstract: Objective: To report a case of rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy of hyperlipidemia.: Case summary: A 30-year-old white man with hypertension, type 1 diabetes mellitus, and hyperlipidemia was hospitalized ... ...

Abstract Objective: To report a case of rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy of hyperlipidemia.
Case summary: A 30-year-old white man with hypertension, type 1 diabetes mellitus, and hyperlipidemia was hospitalized due to myalgias, nausea, and vomiting that began after he started working as a jackhammer operator 4 days previously. His medications were lisinopril, aspirin, insulin, and gemfibrozil. Creatine kinase and creatinine, which previously had been mildly elevated and normal, respectively, were markedly elevated, consistent with rhabdomyolysis with acute renal failure.
Discussion: As of December 8, 2003, this is the only report of a patient with normal baseline creatinine level who developed rhabdomyolysis with acute renal failure associated with gemfibrozil monotherapy. Strenuous exertion, hypovolemia, and lisinopril use may have contributed to the severity of illness. An objective causality assessment revealed that an adverse drug reaction to gemfibrozil was possible.
Conclusions: Gemfibrozil monotherapy of hyperlipidemia may predispose to rhabdomyolysis with acute renal failure. Patients using gemfibrozil should be cautioned regarding strenuous exertion, dehydration, and the need for prompt evaluation of myalgias.
MeSH term(s) Acute Kidney Injury/chemically induced ; Adult ; Creatinine/blood ; Diabetes Mellitus, Type 1/complications ; Gemfibrozil/adverse effects ; Humans ; Hyperlipidemias/complications ; Hyperlipidemias/drug therapy ; Hypertension/complications ; Hypolipidemic Agents/adverse effects ; Male ; Physical Exertion ; Rhabdomyolysis/chemically induced ; Rhabdomyolysis/physiopathology
Chemical Substances Hypolipidemic Agents ; Creatinine (AYI8EX34EU) ; Gemfibrozil (Q8X02027X3)
Language English
Publishing date 2004-02
Publishing country United States
Document type Case Reports ; Journal Article
ZDB-ID 1101370-9
ISSN 1542-6270 ; 1060-0280
ISSN (online) 1542-6270
ISSN 1060-0280
DOI 10.1345/aph.1D282
Shelf mark
Zs.A 900: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top